Live Chat ×
Skip to main content

ONS Symposium 2017 - Advances in Treating MDS and Related Bone Marrow Failure Diseases: The Role of Nurses in Managing Therapy and Personalizing Care

Release Date: June 1, 2017

Expiration Date: June 1, 2019

Estimated Time of Completion: 1.5 hours

Description
This symposium was recorded at the ONS 42nd Annual Congress in Denver, CO on May 4, 2017. The program focuses on recent advances in diagnosing and treating myelodysplastic syndromes and related diseases, including AML and MDS/MPN overlap, and the role of nurses in disease management.

Moderator:
Nancy Corbitt, BSN, RN, OCN, CRNI
University of Maryland Greenebaum Cancer Center, Baltimore, MD
Presenters: 
Lisa Barbarotta, MSN, APRN-BC, AOCNS
Smilow Cancer Hospital, Yale Medical Center, New Haven, CT
Hetty Carraway, MD, MBA Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
Eric Parsons, RN Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Learning Objectives
  1. Discuss the incidence and current tools used for prognosis in MDS
  2. Identify molecular mutations in patients with ICUS and MDS
  3. Identify new treatment options available for low-risk and high-risk MDS patients
  4. Identify strategies/treatment options to cure MDS, including the role of BMT and use of mutation status to predict risks/benefit outcomes
  5. Identify comorbidities and management of side effects that impact MDS treatment
  6. Review informational needs of patients with MDS and related diseases
  7. Review strategies for patient engagement
  8. Identify barriers to effective communication
  9. Identify strategies to improve communication and personalize patient education

Target Audience

This activity is intended for Oncology Nurses, Advanced Practice Nurses, Nurse Practitioners, Physician Assistants, Certified Case Managers, Oncology Social Workers, nursing students and allied health professionals interested in the treatment and management of MDS patients.

Accreditation
This continuing education activity was approved by the Oncology Nursing Society. ONS is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

If you wish to receive continuing education credits for this program, please proceed to the assessment and evaluation sections upon completion of the program.   

If you do not need the CE credits for this program, AAMDSIF would appreciate your completion of the evaluation survey below; your feedback will help us develop future program content.